SCOPUS 정보 검색 플랫폼

CMAJ. Canadian Medical Association Journal

Volumn 167, Issue 9, 2002, Pages 981-983

Drug marketing: Unsafe at any dose?;La commercialisation des médicaments: Dangereuse à toute dose?

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL;

AEROSOL; ASTHMA; CANADA; DISEASE SEVERITY; DRUG MARKETING; DRUG SAFETY; DRUG USE; EDITORIAL; HEALTH SERVICE; MAINTENANCE THERAPY; MEDICAL SOCIETY; PATIENT CARE; THORAX SURGERY;

EID: 0036979672 PISSN: 08203946 EISSN: None Source Type: Journal
DOI: None Document Type: Editorial

Times cited : (3)

References (3)

1
- 0347419360
- 2-agonists be prescribed as initial maintenance treatment for asthma?
- 2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ 2002;167 (9):1008-9.
- (2002) CMAJ , vol.167 , Issue.9 , pp. 1008-1009
- Lemière, C.¹ Becker, A.² Boulet, L.P.³ Bowie, D.⁴ Cartier, A.⁵ Cockcroft, D.⁶

2
- 0033619704
- Canadian asthma consensus report, 1999
- Canadian Asthma Consensus Group. Canadian asthma consensus report, 1999. CMAJ 1999;161(11 Suppl):1-62.
- (1999) CMAJ , vol.161 , Issue.SUPPL. 11 , pp. 1-62

3
- 0012996139
- Response to the recommendations to Health Canada of the Coroner's Jury Investigation into the death of Vanessa Young. Available: www.hc-sc.gc.ca/english/protection/vanessa_young/key_initiatives.html (accessed 2002 Sept 23).
- Response to the Recommendations to Health Canada of the Coroner's Jury Investigation into the Death of Vanessa Young

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.